About
TearSolutions develops Lacripep, a proprietary topical peptide therapy derived from the tear protein Lacritin, designed to treat ocular surface diseases such as dry eye by restoring tear film stability and corneal health.
Explore TearSolutions's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.